Why are formulas containing omega-3 fatty acids recommended in ALI and ARDS?

Why are formulas containing omega-3 fatty acids recommended in ALI and ARDS?

• A. They increase prostaglandins and leukotrienes
• B. They down regulate the inflammatory response by producing less inflammatory prostaglandins and leukotrienes
• C. They cause hyperlipidemia
• D. They improve renal function

Answer: (B)

Modulating inflammatory mediators with omega-3 fatty acids is an important concept in ALI and ARDS management. Omega-3s in nutrition formulas alter cell membrane fatty acids and shift eicosanoid production away from highly inflammatory mediators. They compete with arachidonic acid for COX and LOX enzymes, leading to the creation of less inflammatory prostaglandins and leukotrienes (for example, EPA-derived PGE3 and LTB5) instead of the more pro-inflammatory PGE2 and LTB4. This reduces neutrophil recruitment and cytokine release, helping limit lung injury and support resolution through specialized pro-resolving mediators like resolvins and protectins. So the primary effect is down regulating the inflammatory response, not increasing inflammation or causing hyperlipidemia, and not directly improving renal function.

Modulating inflammatory mediators with omega-3 fatty acids is an important concept in ALI and ARDS management. Omega-3s in nutrition formulas alter cell membrane fatty acids and shift eicosanoid production away from highly inflammatory mediators. They compete with arachidonic acid for COX and LOX enzymes, leading to the creation of less inflammatory prostaglandins and leukotrienes (for example, EPA-derived PGE3 and LTB5) instead of the more pro-inflammatory PGE2 and LTB4. This reduces neutrophil recruitment and cytokine release, helping limit lung injury and support resolution through specialized pro-resolving mediators like resolvins and protectins. So the primary effect is down regulating the inflammatory response, not increasing inflammation or causing hyperlipidemia, and not directly improving renal function.